In Silico Model

Published by Animal Biotechnology

In silico

This article is a review of the main concepts about In silico modeling of diseases. Examples and applications of In silico modeling for some important categories of diseases (such as for cancers, infectious diseases, and neuronal diseases) are also given.

View this resource Bookmark this resource

In Silico Model in Toxicology and Risk Assessment

Published by Frontiers Media

In silicophysiologically-based kinetic and dynamic modelQSAR model

This article aims to address the latest developments in the area of In silico modelling and New approach methodologies (NAMs) including physiologically-based kinetic and dynamic (PBK-D) model, In silico model for the prediction of toxicological such as QSAR model and machine learning algorithms, the use of quantitative adverse outcome pathways for hazard characterisation of chemicals to cite but a few

View this resource Bookmark this resource

A European standardization framework for data integration and data-driven In Silico Model for personalized medicine – EU-STANDS4PM

Published by EU-STANDS4PM consortium

ethicalIn silicoLegal

This report therefore surveys the legal landscape for health data integration, and the challenges which arise when information is re-used to develop analytical or predictive model, which are then re-applied to a patient population

View this resource Bookmark this resource

European Drosophila Society

Published by n/a

Fruit Fly Model

This site provides a central resource for the European fly community. It contains useful information about the European Drosophila Board, which supports community initiatives and oversees the organisation of the biennial European Drosophila Research Conference.

View this resource Bookmark this resource

Animal models for metabolic, neuromuscular and ophthalmological rare diseases

Published by Macmillan Publishers Limited

Animal ModelFeline ModelInfrafrontierMouse ModelNeuromuscular DiseaseOphtalmological Disease

the article provides a compilation of mammalian animal
models for metabolic, neuromuscular and ophthalmological orphan-designated conditions
based on information gathered by the EMA’s Committee for Orphan Medicinal Products (COMP). It is discussed the predictive value of the models and their advantages and limitations with the aim of highlighting those that are appropriate for the preclinical evaluation of novel
therapies, thereby facilitating further drug development for rare diseases.

View this resource Bookmark this resource

KNOCKOUTS MODEL THE 100 BEST-SELLING DRUGS — WILL THEY MODEL THE NEXT 100?

Published by Nature

Knock-Out Mouse Model

this article is a retrospective evaluation of the knockout phenotypes for the targets of the 100 best-selling drugs indicates that these phenotypes correlate well with known drug efficacy, illuminating a productive path forward for discovering future drug targets

Bookmark this resource